Nuena, Ronald .
HRN: 20-75-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2024
CO-AMOXICLAV 625MG (TAB)
02/27/2024
03/05/2024
ORAL
625 Mg
Every 12 Hours
S/P Mesh Hernioplasty
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes